Should I Buy ZLAB? ZLAB 2026 Analysis

Should You Buy Zai Lab Ltd (ZLAB) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

17.250

1 Day change

0.29%

52 Week Range

44.340

Analysis Updated At

2026/01/26

Zai Lab Ltd (ZLAB) does not present a compelling buy opportunity for a beginner, long-term investor at this time. While the stock has potential upside in the long term, the lack of recent positive momentum, insider selling, and weak financial performance make it prudent to hold off on investing right now.

Technical Analysis

The MACD is above 0 and positively contracting, indicating a neutral to slightly bullish trend. RSI is at 42.529, in the neutral zone, suggesting no clear overbought or oversold conditions. Moving averages are converging, showing no strong directional bias. The current price is below the pivot point of 18.847, with support at 18.148 and resistance at 19.546, indicating limited upward momentum in the short term.

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

The low Option Volume Put-Call Ratio indicates bullish sentiment in the options market, but the Open Interest Put-Call Ratio is neutral, suggesting no strong directional bias overall.

Technical Summary

Sell

Buy

Positive Catalysts

The biotech sector is expected to recover, which could benefit ZLAB in the long term.

Neutral/Negative Catalysts

Insiders are selling heavily, with a 2820.31% increase in selling activity over the last month. Goldman Sachs removed ZLAB from its APAC Conviction List. The stock is down 1.80% in pre-market trading, reflecting weak short-term sentiment. No recent news or event-driven catalysts to drive the stock higher.

Financial Performance

In Q3 2025, revenue increased by 13.52% YoY to $116.1M, but net income dropped by 13.70% YoY to -$35.96M. EPS fell by 25% YoY to -0.03, and gross margin declined by 5.90% YoY to 60.13%. These trends indicate improving top-line growth but worsening profitability metrics.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

UBS issued a Buy rating with a $35 price target, citing long-term potential in the biotech sector. However, Goldman Sachs removed ZLAB from its APAC Conviction List, reflecting mixed sentiment among analysts.

5 Analyst Rating

Wall Street analysts forecast ZLAB stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ZLAB is 47.93 USD with a low forecast of 25.7 USD and a high forecast of 74 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

4 Buy

1 Hold

0 Sell

Strong Buy

Current: 17.200

Low

25.7

Averages

47.93

High

Current: 17.200

Low

25.7

Averages

47.93

High

UBS

Buy

initiated

$35

AI Analysis

2026-01-07

Reason

UBS

Price Target

$35

AI Analysis

2026-01-07

initiated

Buy

Reason

UBS initiated coverage of Zai Lab (ZLAB) with a Buy rating and $35 price target as the analyst initiated or assumed coverage on 22 small-to-mid cap biotech names. After a rough period, biotech fundamentals are now inflecting, contends the analyst, who expects investor confidence to recover and sees this positioning biotech for strong performance in 2026. Among the group, top picks include Apogee Therapeutics (APGE), Cogent Biosciences (COGT), Kodiak Sciences (KOD), Ideaya Biosciences (IDYA), Inventiva (IVA), SAB Biotherapeutics (SABS) and Ventyx Biosciences (VTYX), which the analyst highlights as having key upcoming catalysts, de-risked best-in-class portfolios, strong data, and broader pipelines.

Goldman Sachs

downgrade

2025-11-03

Reason

Goldman Sachs

Price Target

2025-11-03

downgrade

Reason

Goldman Sachs analysts removed Zai Lab from the firm's APAC Conviction List as part of its monthly update.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for ZLAB

Unlock Now

ZLAB Should I Buy

ZLAB Should I Buy

Should You Buy Zai Lab Ltd (ZLAB) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch